The University of Chicago Header Logo

Connection

Walter M. Stadler to Pyrazoles

Back to Details
This is a "connection" page, showing publications Walter M. Stadler has written about Pyrazoles.
Walter M. Stadler
Connection Strength
0.046
Pyrazoles
  1. Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma. JCO Precis Oncol. 2022 02; 6:e2100448.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.